SCHEMBL23309517

SCHEMBL23309517

O=C(Nc1c(F)c(F)c(C(F)(F)F)c(F)c1F)c1cc(F)nc(F)c1F

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 3/20 0.42
▸ MAOA P21397 2/20 0.42
▸ MEN1 O00255 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ NFKB1 P19838 3/20 0.34
▸ ATF1 P18846 1/20 0.34
▸ JUN P05412 2/20 0.33
▸ NFKB2 Q00653 2/20 0.33
▸ RELA Q04206 2/20 0.33
▸ DHODH Q02127 1/20 0.33
▸ XPO1 O14980 3/20 0.33
▸ SORT1 Q99523 3/20 0.32
▸ TSHR P16473 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31
▸ P2RX1 P51575 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309614 0.75 LCK (0.45) SMN1; SMN2
SCHEMBL23309730 0.75 KMT2A (0.47) MAOBMAOAMEN1HTTKMT2A
SCHEMBL23309594 0.74 POLB (0.50) MAOBMAOAKMT2ATSHR
SCHEMBL23309568 0.73 P2RX1 (0.59) MAOBMEN1HTTKMT2ASMN1; SMN2
SCHEMBL23309505 0.72 ALDH1A1 (0.43) MAOBMAOAMEN1HTTKMT2A
SCHEMBL23309490 0.72 GAA (0.51) MAOBMAOAMEN1HTTKMT2A
SCHEMBL23309502 0.72 NFKB1 (0.51) MAOBMEN1HTTKMT2ANFKB1
SCHEMBL15410721 0.72 MEN1 (0.56) MEN1HTTKMT2ASMN1; SMN2TDP1
SCHEMBL23309725 0.72 GAA (0.43) MAOBMAOA
SCHEMBL15410871 0.71 TLR8 (0.51) MEN1KMT2AP2RX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL MAOB 2341/4885MAOA 1498/4885MEN1 1633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback